Cell-based therapy of diabetes: What are the new sources of beta cells?

Diabetes and Metabolism

Volumn 37, Issue 5, 2011, Pages 371-375

  Soggia, A ^a   Hoarau, E ^a   Bechetoille, C ^a   Simon, M T ^a   Heinis, M ^a   Duvillie B ^a  

^a INSERM   (France)

Author keywords

Beta cells; Development; Pancreas; Review; Stem cells

Indexed keywords

C PEPTIDE; HEMOGLOBIN A1C; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

CELL DIFFERENTIATION; CELL FUNCTION; CELL THERAPY; CELL TYPE; CLINICAL PROTOCOL; EMBRYONIC STEM CELL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN BLOOD LEVEL; REVIEW; SCORING SYSTEM; STEM CELL TRANSPLANTATION;

DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS TRANSPLANTATION; STEM CELL TRANSPLANTATION;

EID: 81055140543     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2011.05.007     Document Type: Review

References (42)

1. Shapiro A.M., Lakey J.R., Ryan E.A., Korbutt G.S., Toth E., Warnock G.L., et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000, 343:230-238.
2. Ryan E.A., Paty B.W., Senior P.A., Bigam D., Alfadhli E., Kneteman N.M., et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005, 54:2060-2069.
3. Vantyghem M.C., Kerr-Conte J., Arnalsteen L., Sergent G., Defrance F., Gmyr V., et al. Primary graft function, metabolic control, and graft survival after islet transplantation. Diabetes Care 2009, 32:1473-1478.
4. Lechner A., Habener J.F. Stem/progenitor cells derived from adult tissues: potential for the treatment of diabetes mellitus. Am J Physiol Endocrinol Metab 2003, 284:E259-E266.
5. Garkavenko O., Dieckhoff B., Wynyard S., Denner J., Elliott R.B., Tan P.L., et al. Absence of transmission of potentially xenotic viruses in a prospective pig to primate islet xenotransplantation study. J Med Virol 2008, 80:2046-2052.
6. Kroon E., Martinson L.A., Kadoya K., Bang A.G., Kelly O.G., Eliazer S., et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 2008, 26:443-452.
7. D'Amour K.A., Bang A.G., Eliazer S., Kelly O.G., Agulnick A.D., Smart N.G., et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 2006, 24:1392-1401.
8. D'Amour K.A., Agulnick A.D., Eliazer S., Kelly O.G., Kroon E., Baetge E.E. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 2005, 23:1534-1541.
9. Borowiak M., Maehr R., Chen S., Chen A.E., Tang W., Fox J.L., et al. Small molecules efficiently direct endodermal differentiation of mouse and human embryonic stem cells. Cell Stem Cell 2009, 4:348-358.
10. Chen S., Borowiak M., Fox J.L., Maehr R., Osafune K., Davidow L., et al. A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Nat Chem Biol 2009, 5:258-265.
11. Maehr R., Chen S., Snitow M., Ludwig T., Yagasaki L., Goland R., et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci U S A 2009, 106:15768-15773.
12. Takahashi K., Okita K., Nakagawa M., Yamanaka S. Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2007, 2:3081-3089.
13. Pasi C.E., Dereli-Oz A., Negrini S., Friedli M., Fragola G., Lombardo A., et al. Genomic instability in induced stem cells. Cell Death Differ 2011, 18:745-753.
14. Meivar-Levy I., Ferber S. Regenerative medicine: using liver to generate pancreas for treating diabetes. Isr Med Assoc J 2006, 8:430-434.
15. Karnieli O., Izhar-Prato Y., Bulvik S., Efrat S. Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells 2007, 25:2837-2844.
16. Chao K.C., Chao K.F., Fu Y.S., Liu S.H. Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes. PLoS One 2008, 3:e1451.
17. Nishiyama N., Miyoshi S., Hida N., Uyama T., Okamoto K., Ikegami Y., et al. The significant cardiomyogenic potential of human umbilical cord blood-derived mesenchymal stem cells in vitro. Stem Cells 2007, 25:2017-2024.
18. Karahuseyinoglu S., Cinar O., Kilic E., Kara F., Akay G.G., Demiralp D.O., et al. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 2007, 25:319-331.
19. Conconi M.T., Burra P., Di Liddo R., Calore C., Turetta M., Bellini S., et al. CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential. Int J Mol Med 2006, 18:1089-1096.
20. Kadam S.S., Bhonde R.R. Islet neogenesis from the constitutively nestin expressing human umbilical cord matrix derived mesenchymal stem cells. Islets 2010, 2:112-120.
21. Davani B., Ikonomou L., Raaka B.M., Geras-Raaka E., Morton R.A., Marcus-Samuels B., et al. Human islet-derived precursor cells are mesenchymal stromal cells that differentiate and mature to hormone-expressing cells in vivo. Stem Cells 2007, 25:3215-3222.
22. Gershengorn M.C., Hardikar A.A., Wei C., Geras-Raaka E., Marcus-Samuels B., Raaka B.M. Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells. Science 2004, 306:2261-2264.
23. Wei C., Geras-Raaka E., Marcus-Samuels B., Oron Y., Gershengorn M.C. Trypsin and thrombin accelerate aggregation of human endocrine pancreas precursor cells. J Cell Physiol 2006, 206:322-328.
24. Juhl K., Bonner-Weir S., Sharma A. Regenerating pancreatic beta-cells: plasticity of adult pancreatic cells and the feasibility of in-vivo neogenesis. Curr Opin Organ Transplant 2010, 15:79-85.
25. Li W.C., Rukstalis J.M., Nishimura W., Tchipashvili V., Habener J.F., Sharma A., et al. Activation of pancreatic-duct-derived progenitor cells during pancreas regeneration in adult rats. J Cell Sci 2010, 123:2792-2802.
26. Xu X., D'Hoker J., Stange G., Bonne S., De Leu N., Xiao X., et al. Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 2008, 132:197-207.
27. Ferber S., Halkin A., Cohen H., Ber I., Einav Y., Goldberg I., et al. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med 2000, 6:568-572.
28. Gefen-Halevi S., Rachmut I.H., Molakandov K., Berneman D., Mor E., Meivar-Levy I., et al. NKX6.1 promotes PDX-1-induced liver to pancreatic beta-cells reprogramming. Cell Reprogram 2010, 12:655-664.
29. Thorel F., Nepote V., Avril I., Kohno K., Desgraz R., Chera S., et al. Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature 2010, 464:1149-1154.
30. Haumaitre C., Lenoir O., Scharfmann R. Histone deacetylase inhibitors modify pancreatic cell fate determination and amplify endocrine progenitors. Mol Cell Biol 2008, 28:6373-6383.
31. Guillemain G., Filhoulaud G., Da Silva-Xavier G., Rutter G.A., Scharfmann R. Glucose is necessary for embryonic pancreatic endocrine cell differentiation. J Biol Chem 2007, 282:15228-15237.
32. Filhoulaud G., Guillemain G., Scharfmann R. The hexosamine biosynthesis pathway is essential for pancreatic beta cell development. J Biol Chem 2009, 284:24583-24594.
33. Heinis M., Simon M.T., Duvillie B. New insights into endocrine pancreatic development: the role of environmental factors. Horm Res Paediatr 2010, 74:77-82.
34. Heinis M., Simon M.T., Ilc K., Mazure N.M., Pouyssegur J., Scharfmann R., et al. Oxygen tension regulates pancreatic beta-cell differentiation through hypoxia-inducible factor 1alpha. Diabetes 2010, 59:662-669.
35. Shah S.R., Esni F., Jakub A., Paredes J., Lath N., Malek M., et al. Embryonic mouse blood flow and oxygen correlate with early pancreatic differentiation. Dev Biol 2011, 349:342-349.
36. Zehetner J., Danzer C., Collins S., Eckhardt K., Gerber P.A., Ballschmieter P., et al. PVHL is a regulator of glucose metabolism and insulin secretion in pancreatic beta cells. Genes Dev 2008, 22:3135-3146.
37. Puri S., Cano D.A., Hebrok M. A role for von Hippel-Lindau protein in pancreatic beta-cell function. Diabetes 2009, 58:433-441.
38. Cantley J., Selman C., Shukla D., Abramov A.Y., Forstreuter F., Esteban M.A., et al. Deletion of the von Hippel-Lindau gene in pancreatic beta cells impairs glucose homeostasis in mice. J Clin Invest 2009, 119:125-135.
39. Beall C.M., Cavalleri G.L., Deng L., Elston R.C., Gao Y., Knight J., et al. Natural selection on EPAS1 (HIF2alpha) associated with low hemoglobin concentration in Tibetan highlanders. Proc Natl Acad Sci U S A 2010, 107:11459-11464.
40. Percy M.J., Furlow P.W., Lucas G.S., Li X., Lappin T.R., McMullin M.F., et al. A gain-of-function mutation in the HIF2A gene in familial erythrocytosis. N Engl J Med 2008, 358:162-168.
41. Yamada N., Horikawa Y., Oda N., Iizuka K., Shihara N., Kishi S., et al. Genetic variation in the hypoxia-inducible factor-1alpha gene is associated with type 2 diabetes in Japanese. J Clin Endocrinol Metab 2005, 90:5841-5847.
42. Nagy G., Kovacs-Nagy R., Kereszturi E., Somogyi A., Szekely A., Nemeth N., et al. Association of hypoxia inducible factor-1 alpha gene polymorphism with both type 1 and type 2 diabetes in a Caucasian (Hungarian) sample. BMC Med Genet 2009, 10:79.